Are Hemo Organic latest results good or bad?

Hemo Organic has reported its financial results for the quarter ending March 2025, showcasing notable improvements across several key metrics. The Operating Profit Before Depreciation, Interest, and Taxes (PBDIT) reached Rs 0.14 crore, which is the highest figure recorded in the last five quarters. Additionally, the Profit Before Tax (PBT) also achieved a five-quarter high at Rs 0.15 crore, indicating a favorable trend in profitability. The Profit After Tax (PAT) for the quarter stood at Rs 0.37 crore, again reflecting the highest performance in the past five quarters, suggesting a positive trajectory in the company's financial health.
Earnings per Share (EPS) reached Rs 1.07, marking the highest level in the last five quarters, which indicates enhanced earnings for shareholders. However, it is worth noting that the company experienced a revision in its evaluation during this reporting period.

In terms of quarterly performance, net sales remained unchanged compared to the previous quarter, while the standalone net profit exhibited a significant growth rate of 384.62%, contrasting with a decline in the prior quarter. The operating profit margin remained consistent at 5.81%, reflecting stability in operational efficiency.

Overall, Hemo Organic's latest results highlight a positive operational trend, particularly in profitability metrics, despite the static net sales.